Amylyx Pharmaceuticals, Inc.
AMLX
$32.92
-$0.96-2.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 250.76M | 279.77M | 316.98M | 343.99M | 180.83M |
| Total Receivables | 500.00K | 100.00K | 188.00K | 232.00K | 306.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.08M | 5.16M | 6.50M | 9.16M | 11.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 256.34M | 285.02M | 323.67M | 353.38M | 186.89M |
|
|
|||||
| Total Current Assets | 256.34M | 285.02M | 323.67M | 353.38M | 186.89M |
| Net Property, Plant & Equipment | 4.74M | 5.09M | 5.49M | 5.88M | 6.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.49M | 3.49M | 3.48M | 3.48M | 1.45M |
| Total Assets | 264.56M | 293.60M | 332.65M | 362.74M | 194.60M |
|
|
|||||
| Total Accounts Payable | 5.53M | 3.53M | 3.52M | 5.34M | 3.29M |
| Total Accrued Expenses | 14.61M | 11.28M | 17.91M | 19.47M | 17.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.01M | 1.16M | 1.26M | 981.00K | 665.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.15M | 15.97M | 22.69M | 25.79M | 21.42M |
|
|
|||||
| Total Current Liabilities | 21.15M | 15.97M | 22.69M | 25.79M | 21.42M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.25M | 4.48M | 4.70M | 4.95M | 5.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.40M | 20.44M | 27.39M | 30.75M | 26.72M |
|
|
|||||
| Common Stock & APIC | 1.08B | 1.07B | 1.06B | 1.05B | 851.37M |
| Retained Earnings | -836.13M | -792.71M | -751.43M | -718.43M | -684.04M |
| Treasury Stock & Other | 19.00K | 240.00K | 404.00K | 815.00K | 551.00K |
| Total Common Equity | 239.17M | 273.16M | 305.26M | 332.00M | 167.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 239.17M | 273.16M | 305.26M | 332.00M | 167.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 239.17M | 273.16M | 305.26M | 332.00M | 167.88M |
|
|
|||||